NCT00712712 2025-08-29
MEDOR
Institut Bergonié
Phase 2 Completed
Clinical Trials
12 trialsNCT03753659 2024-07-22
IMMULAB - Immunotherapy With Pembrolizumab in Combination With Local Ablation in Hepatocellular Carcinoma (HCC)
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Phase 2 Completed
NCT03101475 2022-05-31
ILOC
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Completed
NCT00029029 2020-08-12
Radiofrequency Ablation in Relieving Pain in Patients With Bones Metastases
Mayo Clinic
Phase 2 Completed
NCT00024076 2020-08-03
Radiofrequency Ablation in Treating Patients With Refractory or Advanced Lung Cancer
Jonsson Comprehensive Cancer Center
Phase 2 Completed
NCT00004136 2018-11-06
Heat Therapy in Treating Patients With Unresectable Primary or Metastatic Liver Cancer
M.D. Anderson Cancer Center
Phase 2 Completed
NCT00004142 2018-10-26
Radiofrequency Ablation Followed By Hepatic Artery Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver
M.D. Anderson Cancer Center
Phase 2 Completed
NCT00030563 2017-04-17
Surgery With or Without Radiofrequency Ablation Followed by Irinotecan in Treating Patients With Colorectal Cancer That is Metastatic to the Liver
University of Washington
Phase 2 Completed
NCT02468076 2016-05-11
IGNITE-1
Universitaire Ziekenhuizen KU Leuven
Phase 2 Completed
NCT00019955 2015-04-29
Radiofrequency Interstitial Tissue Ablation in Treating Patients With Localized Renal Cell Carcinoma (Kidney Cancer)
National Cancer Institute (NCI)
Phase 2 Completed
NCT00039507 2010-02-12
Radiofrequency Ablation During Surgery in Treating Patients With Non-Small Cell Lung Cancer
Fox Chase Cancer Center
Phase 2 Completed
NCT00180856 2005-09-16
Radiofrequency Ablation of Lung Tumors
Gustave Roussy, Cancer Campus, Grand Paris
Phase 2 Completed